Navigation Links
Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
Date:6/23/2008

discontinuance of the Company's embolic protection platform of $3.1 million, or $0.25 per share. Including these items, the 2008 fourth quarter loss per share is expected to be in a range of ($0.08) to ($0.09) compared to a loss of ($0.15) per share for the same period in fiscal year 2007.

Fiscal Year 2008

Fiscal year 2008 net biomaterials sales guidance was previously announced in a range of $46.9 to $47.1 million. The Company is now estimating biomaterials product sales of $47.2 to $47.4 million, an increase of 15% over the prior year, and total net sales, including endovascular products, in the range of $53.2 to $53.4 million, an 18% increase from fiscal year 2007. Fiscal year 2008 royalties are estimated to be $25.7 to $25.8 million, representing 5% growth from fiscal year 2007. Total revenues are expected to be in a range of $78.9 to $79.2 million, a 13% increase from the prior fiscal year.

Fiscal year 2008 adjusted diluted earnings per share* are expected to be in the range of $0.96 to $0.97, representing an increase of 81% to 83% compared to fiscal year 2007. Estimated adjusted diluted earnings per share for fiscal year 2008 exclude after-tax charges of $7.3 million, or $0.58 per share, for the acceleration of stock awards, discontinuation of the Company's embolic protection platform, and sale of the Company's endovascular business. Adjusted diluted earnings per share for the fiscal year 2007 of $0.53 excluded an after-tax charge for the discontinuance of the Company's embolic protection platform of $3.1 million, or $0.25 per share. Including these items, reported diluted earnings per share for fiscal 2008 are expected to be in a range of $0.38 to $0.39, representing a 31% to 34% increase compared to fiscal year 2007 reported diluted earnings per share of $0.29.

"We are completing our fiscal year with another strong quarter," commented Joe Kaufmann, President and CEO. "Our Biomaterials business, notably the orthopaedic segment, con
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Announces $25 Million Stock Repurchase Program
3. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
6. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
7. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
8. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
9. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
10. Kensey Nash Reports Third Quarter Record Revenue and Sales
11. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Plano, Texas (PRWEB) October 22, 2014 ... convenience of completing their continuing education at home ... now have access to 20 brand new, premium ... HomeCEUConnection.com’s robust catalog of over 2,000 hours ... to fully customize their educational experience. With such ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, announced ... will be speaking on the subject of “Event Technology ... 28, at the Holiday Inn in New York City. ... as a Tech Demo at 12:45pm, to educate event ... engaging event experience. , The Annual Meetings Technology Expo ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter ... among young adult men may lead to increased blood pressure, ... cause a similar rise in blood pressure for young adult ... when young adult women drank lightly or moderately, their risk ... found. "This finding parallels studies in older adult men ...
(Date:10/22/2014)... By Dennis Thompson ... -- U.S. health officials on Monday officially tightened guidelines for ... with no skin exposure and use of a respirator at ... Prevention decided to issue the tougher rules after two Dallas ... diagnosed in the United States, Liberian national Thomas Eric Duncan. ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
... Celebrate you" health fair will provide free, health screenings ... WICHITA, Kan., July 30 As summer vacation slowly ... the return to school.,Getting ready to go back to ... To help parents, the "Celebrate,Your Children, Celebrate You," health ...
... treated for breast cancer did not know that their odds ... whether they undergo mastectomy or breast conserving surgery. Minority women ... factor of their treatment decision, according to a study from ... were also less likely to know about relative survival rates ...
... July 30 Dyadem today announced that ... Hofliger, a Germany-based builder of,production equipment for ... FMEA-Med software to help its customers minimize ... of its specialized,pharmaceutical equipment., Harro Hofliger ...
... conjunction,with DURECT Corporation,s (Nasdaq: DRRX ) second ... to listen to the conference call,that will be ... 6, 2008,at 9:00 a.m. EDT (6:00 a.m. PDT)., ... audio webcast of the presentation will be available ...
... Joins Premier Professional Online Medical Resource as ... ... The Doctor,s Channel, (http://www.thedoctorschannel.com ), today announced the appointment of ... Contributing Editor. Hailed by CNBC as the "educational,YouTube" for doctors, ...
... of Love Canal Are Not Counted In the NY State,Department ... What Have We Learned?, FALLS CHURCH, Va., July 30 ... Environment & Justice:, WHAT:, Press Conference & walking ... once stood., Rain or Shine, WHEN:, Friday, ...
Cached Medicine News:Health News:UniCare Health Plan Teams With Local Organizations for Community and Wellness Fair 2Health News:Minorities less likely to know about breast cancer treatment options 2Health News:Minorities less likely to know about breast cancer treatment options 3Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 3Health News:DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call 2Health News:The Doctor's Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team 2Health News:The Doctor's Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team 3Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, 2014 ... announced they have entered into a license and ... to target cancers. PhosImmune possesses technology ... the surfaces of tumor cells in association with ... from proteins that play a role in malignancy, ...
(Date:10/22/2014)... SHANGHAI , Oct. 22, 2014 /PRNewswire/ ... FMI ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... Foundation Medicine,s comprehensive genomic profiling to biopharmaceutical companies conducting ... Under the terms of the collaboration, Foundation ... laboratory component of Foundation Medicine,s FoundationOne® assay at the ...
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  ResMed ... availability of the ResMed Data Exchange program, a ... home medical equipment (HME) and other health care ... timely, secure access to critical patient information. It ... ResMed,s AirView™ and U-Sleep™ patient management platforms with ...
Breaking Medicine Technology:Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5ResMed Launches ResMed Data Exchange 2
... , RICHMOND, Va., Nov. 4 Filtrona Porous Technologies, ... for the medical device and healthcare industry, and a ... recently developed a unique foam-fiber hybrid component for select ... Referred to as MediSponge® RBR , the patent-pending ...
... Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management ... non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and ... today that it has initiated a clinical study of ... in patients with Type 1 and Type 2 diabetes. ...
Cached Medicine Technology:Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 3
...
... steel construction for lifelong quality. Sealed hydraulic ... chair movement. Soft, contoured cushions with heavy-duty ... counter-balanced slit lamp arm for easy, smooth, ... slit lamp arm for easy access to ...
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: